Healthpeak Properties, Inc. $DOC Stake Boosted by Sanctuary Advisors LLC

Sanctuary Advisors LLC lifted its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 30.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 141,835 shares of the real estate investment trust’s stock after acquiring an additional 32,758 shares during the quarter. Sanctuary Advisors LLC’s holdings in Healthpeak Properties were worth $2,330,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Integrated Wealth Concepts LLC raised its stake in shares of Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after purchasing an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Healthpeak Properties by 110.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after buying an additional 63,930 shares in the last quarter. Woodline Partners LP grew its stake in shares of Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after buying an additional 17,279 shares in the last quarter. Brown Advisory Inc. increased its holdings in Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after buying an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd acquired a new position in Healthpeak Properties in the second quarter worth approximately $3,117,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares in the company, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.23% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. UBS Group lifted their target price on shares of Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Wells Fargo & Company raised their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a report on Wednesday, July 15th. JPMorgan Chase & Co. lifted their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, June 24th. Evercore cut shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective for the company. in a report on Monday, May 11th. Finally, Morgan Stanley restated an “equal weight” rating and set a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and an average price target of $20.62.

Healthpeak Properties Stock Up 1.4%

DOC opened at $22.59 on Wednesday. The business has a 50 day moving average of $20.57 and a 200-day moving average of $18.34. The stock has a market capitalization of $15.58 billion, a price-to-earnings ratio of 70.61, a P/E/G ratio of 3.46 and a beta of 1.02. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $22.72.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.4%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.